Antithrombin-S195A factor Xa-heparin structure reveals the allosteric mechanism of antithrombin activation.

The EMBO Journal
Daniel J D JohnsonJames A Huntington

Abstract

Regulation of blood coagulation is critical for maintaining blood flow, while preventing excessive bleeding or thrombosis. One of the principal regulatory mechanisms involves heparin activation of the serpin antithrombin (AT). Inhibition of several coagulation proteases is accelerated by up to 10,000-fold by heparin, either through bridging AT and the protease or by inducing allosteric changes in the properties of AT. The anticoagulant effect of short heparin chains, including the minimal AT-specific pentasaccharide, is mediated exclusively through the allosteric activation of AT towards efficient inhibition of coagulation factors (f) IXa and Xa. Here we present the crystallographic structure of the recognition (Michaelis) complex between heparin-activated AT and S195A fXa, revealing the extensive exosite contacts that confer specificity. The heparin-induced conformational change in AT is required to allow simultaneous contacts within the active site and two distinct exosites of fXa (36-loop and the autolysis loop). This structure explains the molecular basis of protease recognition by AT, and the mechanism of action of the important therapeutic low-molecular-weight heparins.

References

Oct 29, 1991·Biochemistry·E W DavieW Kisiel
Aug 25, 1983·Journal of Molecular Biology·D J Barlow, J M Thornton
Aug 1, 1993·The Biochemical Journal·B MulloyD B Davies
Apr 1, 1997·Journal of Molecular Graphics & Modelling·R M Esnouf
Feb 7, 1998·Proceedings of the National Academy of Sciences of the United States of America·L JinR W Carrell
Oct 3, 1998·Acta Crystallographica. Section D, Biological Crystallography·A T BrüngerG L Warren
May 23, 2000·Lancet·B Dahlbäck
Aug 10, 2000·Protein Science : a Publication of the Protein Society·P R ElliottD A Lomas
Sep 1, 2000·Journal of Medicinal Chemistry·S MaignanV Mikol
Oct 31, 2001·Nature Structural Biology·S YeE J Goldsmith
Feb 14, 2002·Biochemistry. Biokhimii︠a︡·S Butenas, K G Mann
May 23, 2002·Biochemistry·Chandrashekhara ManithodyAlireza R Rezaie
Aug 10, 2002·Proceedings of the National Academy of Sciences of the United States of America·Trevor P BaglinJames A Huntington
Dec 12, 2002·Chemical Reviews·Peter G W Gettins
May 2, 2003·The Journal of Biological Chemistry·Likui YangAlireza R Rezaie
Jul 23, 2003·Journal of Thrombosis and Haemostasis : JTH·J A Huntington
Aug 9, 2003·Blood·Alec MushunjeJames A Huntington
Nov 19, 2003·The Journal of Biological Chemistry·Daniel J D Johnson, James A Huntington
Jan 24, 2004·Protein Science : a Publication of the Protein Society·Lin ChenAlireza R Rezaie
Jun 17, 2004·Angewandte Chemie·Maurice Petitou, Constant A A van Boeckel
Nov 1, 1994·Acta Crystallographica. Section D, Biological Crystallography·E A Merritt, M E Murphy
Aug 18, 2004·Nature Structural & Molecular Biology·Alexey DementievPeter G W Gettins
Aug 18, 2004·Nature Structural & Molecular Biology·Wei LiJames A Huntington
Aug 18, 2004·Current Opinion in Hematology·Monica SchenoneBruce Furie
Aug 25, 2004·Methods : a Companion to Methods in Enzymology·Zygmunt S Derewenda
Aug 25, 2004·The Journal of Biological Chemistry·Jonathan LangdownJames A Huntington
Sep 1, 2004·Pharmacotherapy·Henry BusseyUNKNOWN Heparin Consensus Group
Nov 19, 2004·The Journal of Biological Chemistry·Wendy J CarterJames A Huntington
Apr 5, 2005·Acta Crystallographica. Section D, Biological Crystallography·Airlie J McCoyRandy J Read

❮ Previous
Next ❯

Citations

Dec 7, 2007·Functional & Integrative Genomics·Thomas H Roberts, Jørn Hejgaard
Nov 28, 2008·Biochemistry·Sophia Schedin-WeissSteven T Olson
Jan 19, 2010·Proceedings of the National Academy of Sciences of the United States of America·Daniel J D JohnsonJames A Huntington
Jul 16, 2010·The Journal of Biological Chemistry·Likui YangAlireza R Rezaie
Feb 22, 2011·The Journal of Biological Chemistry·Tomio YabeMakoto Kiso
Jan 5, 2011·The Journal of Biological Chemistry·Zhonghui LinMingdong Huang
Sep 16, 2006·The Journal of Biological Chemistry·Daniel J D JohnsonJames A Huntington
Oct 11, 2008·The Journal of Biological Chemistry·Maria MitsiMatthew A Nugent
May 26, 2010·The Journal of Biological Chemistry·James C WhisstockJames A Huntington
Aug 31, 2011·Journal of Biomolecular Structure & Dynamics·Poonam SinghMohamad Aman Jairajpuri
Mar 28, 2012·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Iwao Suzuki, Yasushi Ozeki
Aug 25, 2010·Biological Chemistry·James A Huntington, James C Whisstock
Nov 11, 2010·Clinical Chemistry and Laboratory Medicine : CCLM·László MuszbekIstván Komáromi
Dec 4, 2013·Proceedings of the National Academy of Sciences of the United States of America·Shih-Hon LiDaniel A Lawrence
Mar 13, 2014·Annual Review of Biochemistry·Ding Xu, Jeffrey D Esko
Jul 30, 2014·Future Medicinal Chemistry·Mun Peak Nyon, Bibek Gooptu
Aug 26, 2014·Glycoconjugate Journal·Marco GuerriniChristian Viskov
Sep 12, 2012·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Yi-Jie ZhangJin-Ming Liu
Jan 14, 2016·Analytical and Bioanalytical Chemistry·Consuelo N BeecherCynthia K Larive
Sep 14, 2010·Current Opinion in Structural Biology·T R RuddE A Yates
Mar 7, 2009·Journal of Molecular Biology·Stefano RicagnoMartino Bolognesi
May 20, 2009·Journal of Molecular Biology·Jonathan LangdownJames A Huntington
Nov 3, 2006·Current Opinion in Structural Biology·James C Whisstock, Stephen P Bottomley
Aug 1, 2007·Journal of Thrombosis and Haemostasis : JTH·J C RauF C Church
Dec 19, 2008·Chemical Biology & Drug Design·Neha S Gandhi, Ricardo L Mancera
Nov 17, 2011·Physiologia Plantarum·Robert FluhrThomas H Roberts
Aug 4, 2011·Journal of Thrombosis and Haemostasis : JTH·J A Huntington
May 16, 2014·Journal of Thrombosis and Haemostasis : JTH·S AguilaI Martínez-Martínez
Jul 6, 2006·Trends in Biochemical Sciences·James A Huntington

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.